Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
49.8M
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
+1.77M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
+$52.1M
-
Put/Call ratio
-
0.02
-
Number of buys
-
128
-
Number of sells
-
-102
-
Price
-
$35.69
Significant Holders of AtriCure, Inc. - Common Shares (ATRC) as of Q4 2023
268 filings reported holding ATRC - AtriCure, Inc. - Common Shares as of Q4 2023.
AtriCure, Inc. - Common Shares (ATRC) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 49.8M outstanding shares and own 92.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.77M shares), BlackRock Inc. (4.19M shares), ALLIANCEBERNSTEIN L.P. (3.39M shares), Champlain Investment Partners, LLC (2.11M shares), MACQUARIE GROUP LTD (1.45M shares), First Light Asset Management, LLC (1.35M shares), WELLINGTON MANAGEMENT GROUP LLP (1.33M shares), STATE STREET CORP (1.2M shares), Invesco Ltd. (1.16M shares), and FRED ALGER MANAGEMENT, LLC (1.15M shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.